Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

6.93

-0.52 (-6.98%)

At close: Oct 23, 2026, 4:00 PM EDT

6.93

0.00 (-0.07%)

Pre-market: Oct 26, 2026, 6:32 AM EDT

Avalo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	372	329	78	7	47	191
Market Cap Growth	79.11%	323.58%	965.79%	-84.63%	-75.15%	-95.47%
Enterprise Value	-28	218	-1	-1	52	153
Last Close Price	6.93	18.16	7.43	9.10	1209.61	4895.96

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	6299.25	5581.57	176.29	3.79	2.63	35.37
PB Ratio	0.82	3.97	0.58	1.00	-4.35	8.27
P/TBV Ratio	0.85	4.54	0.63	-	-	22.11

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	3699.17	-	-	2.87	28.36

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.01	0.01	0.26	-1.98	1.53
Net Debt / Equity Ratio	-0.89	-1.18	-1.00	-0.75	-0.78	-0.83
Net Debt / EBITDA Ratio	4.38	1.35	3.28	0.24	-0.28	0.24
Net Debt / FCF Ratio	5.86	1.90	2.72	0.18	-0.32	0.27
Asset Turnover	0	0	0.01	0.07	0.32	0.09
Inventory Turnover	-	-	-	-	896.21	2444.83
Quick Ratio	18.94	7.60	19.33	1.64	0.68	2.99
Current Ratio	19.31	8.14	19.95	1.82	0.74	3.11
Return on Equity (ROE)	-36.27%	-72.44%	-50.06%	-	-684.77%	-354.08%
Return on Assets (ROA)	-18.50%	-34.12%	-29.75%	-53.91%	-32.95%	-82.82%
Return on Invested Capital (ROIC)	-517.90%	-	-6834.61%	-359.43%	-396.92%	-1501.54%
Return on Capital Employed (ROCE)	-19.50%	-70.40%	-28.40%	-143.20%	-266.10%	-136.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-60.26%	-23.76%	-45.18%	-432.43%	-87.80%	-44.19%
FCF Yield	-18.37%	-15.63%	-63.10%	-422.75%	-56.58%	-37.19%
Buyback Yield / Dilution	-158.89%	-78.82%	-2599.19%	-608.45%	-8.32%	-41.86%

SEC Filings: 10-K · 10-Q